Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0UK7B
|
|||
Former ID |
DIB011132
|
|||
Drug Name |
REGN1400
|
|||
Drug Type |
Antibody
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Erbb3 tyrosine kinase receptor (Erbb-3) | Target Info | . | [2] |
KEGG Pathway | ErbB signaling pathway | |||
Calcium signaling pathway | ||||
Endocytosis | ||||
Proteoglycans in cancer | ||||
MicroRNAs in cancer | ||||
NetPath Pathway | TNFalpha Signaling Pathway | |||
Panther Pathway | Cadherin signaling pathway | |||
EGF receptor signaling pathway | ||||
Pathway Interaction Database | ErbB2/ErbB3 signaling events | |||
ErbB receptor signaling network | ||||
a6b1 and a6b4 Integrin signaling | ||||
WikiPathways | ErbB Signaling Pathway | |||
Apoptosis-related network due to altered Notch3 in ovarian cancer | ||||
Signaling Pathways in Glioblastoma | ||||
miR-targeted genes in muscle cell - TarBase | ||||
Heart Development |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036915) | |||
REF 2 | J Clin Oncol 32:5s, 2014 (suppl; abstr 2516). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.